114 related articles for article (PubMed ID: 10099133)
1. The identification of myriocin-binding proteins.
Chen JK; Lane WS; Schreiber SL
Chem Biol; 1999 Apr; 6(4):221-35. PubMed ID: 10099133
[TBL] [Abstract][Full Text] [Related]
2. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.
Miyake Y; Kozutsumi Y; Nakamura S; Fujita T; Kawasaki T
Biochem Biophys Res Commun; 1995 Jun; 211(2):396-403. PubMed ID: 7794249
[TBL] [Abstract][Full Text] [Related]
3. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations.
Johnson VJ; He Q; Osuchowski MF; Sharma RP
Toxicology; 2004 Sep; 201(1-3):67-75. PubMed ID: 15297021
[TBL] [Abstract][Full Text] [Related]
4. Reactions of serine palmitoyltransferase with serine and molecular mechanisms of the actions of serine derivatives as inhibitors.
Ikushiro H; Hayashi H; Kagamiyama H
Biochemistry; 2004 Feb; 43(4):1082-92. PubMed ID: 14744154
[TBL] [Abstract][Full Text] [Related]
5. A mammalian homolog of the yeast LCB1 encodes a component of serine palmitoyltransferase, the enzyme catalyzing the first step in sphingolipid synthesis.
Hanada K; Hara T; Nishijima M; Kuge O; Dickson RC; Nagiec MM
J Biol Chem; 1997 Dec; 272(51):32108-14. PubMed ID: 9405408
[TBL] [Abstract][Full Text] [Related]
6. Fungal metabolite sulfamisterin suppresses sphingolipid synthesis through inhibition of serine palmitoyltransferase.
Yamaji-Hasegawa A; Takahashi A; Tetsuka Y; Senoh Y; Kobayashi T
Biochemistry; 2005 Jan; 44(1):268-77. PubMed ID: 15628868
[TBL] [Abstract][Full Text] [Related]
7. Purification of the serine palmitoyltransferase complex responsible for sphingoid base synthesis by using affinity peptide chromatography techniques.
Hanada K; Hara T; Nishijima M
J Biol Chem; 2000 Mar; 275(12):8409-15. PubMed ID: 10722674
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
[TBL] [Abstract][Full Text] [Related]
9. Myriocin, a serine palmitoyltransferase inhibitor, alters regional brain neurotransmitter levels without concurrent inhibition of the brain sphingolipid biosynthesis in mice.
Osuchowski MF; Johnson VJ; He Q; Sharma RP
Toxicol Lett; 2004 Feb; 147(1):87-94. PubMed ID: 14700532
[TBL] [Abstract][Full Text] [Related]
10. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
[TBL] [Abstract][Full Text] [Related]
11. Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase.
Hanada K; Hara T; Fukasawa M; Yamaji A; Umeda M; Nishijima M
J Biol Chem; 1998 Dec; 273(50):33787-94. PubMed ID: 9837968
[TBL] [Abstract][Full Text] [Related]
12. Human and murine serine-palmitoyl-CoA transferase--cloning, expression and characterization of the key enzyme in sphingolipid synthesis.
Weiss B; Stoffel W
Eur J Biochem; 1997 Oct; 249(1):239-47. PubMed ID: 9363775
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver.
He Q; Johnson VJ; Osuchowski MF; Sharma RP
Mycopathologia; 2004 Apr; 157(3):339-47. PubMed ID: 15180163
[TBL] [Abstract][Full Text] [Related]
14. Serine palmitoyltransferase, the first step enzyme in sphingolipid biosynthesis, is involved in nonhost resistance.
Takahashi Y; Berberich T; Kanzaki H; Matsumura H; Saitoh H; Kusano T; Terauchi R
Mol Plant Microbe Interact; 2009 Jan; 22(1):31-8. PubMed ID: 19061400
[TBL] [Abstract][Full Text] [Related]
15. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
16. Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis.
Bejaoui K; Uchida Y; Yasuda S; Ho M; Nishijima M; Brown RH; Holleran WM; Hanada K
J Clin Invest; 2002 Nov; 110(9):1301-8. PubMed ID: 12417569
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration.
Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye KA; Stocker R; Jessup W; Garner B
Biochem Pharmacol; 2007 May; 73(9):1340-6. PubMed ID: 17239824
[TBL] [Abstract][Full Text] [Related]
18. Theoretical study of myriocin-binding mechanism targeting serine palmitoyltransferase.
Yu L; Jiang Y; Xu L; Jin J; Pei Z; Zhu J
Chem Biol Drug Des; 2022 Mar; 99(3):373-381. PubMed ID: 34862732
[TBL] [Abstract][Full Text] [Related]
19. Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in sphingolipid biosynthesis, in intact cells. A novel evaluation system using an SPT-defective mammalian cell mutant.
Hanada K; Nishijima M; Fujita T; Kobayashi S
Biochem Pharmacol; 2000 May; 59(10):1211-6. PubMed ID: 10736421
[TBL] [Abstract][Full Text] [Related]
20. Myriocin, a serine palmitoyltransferase inhibitor, blocks cytokinesis in Leishmania (Viannia) braziliensis promastigotes.
Castro EV; Yoneyama KG; Haapalainen EF; Toledo MS; Takahashi HK; Straus AH
J Eukaryot Microbiol; 2013; 60(4):377-87. PubMed ID: 23659342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
